NewGenIvf Group Limited (NASDAQ:NIVF) Sees Large Increase in Short Interest

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant growth in short interest in January. As of January 30th, there was short interest totaling 64,198 shares, a growth of 296.5% from the January 15th total of 16,190 shares. Approximately 9.6% of the company’s stock are sold short. Based on an average daily volume of 1,854,872 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 1,854,872 shares, the days-to-cover ratio is presently 0.0 days. Approximately 9.6% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

NIVF has been the topic of a number of research analyst reports. Wall Street Zen upgraded NewGenIvf Group to a “hold” rating in a research report on Saturday, December 6th. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Wednesday, January 28th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

NewGenIvf Group Stock Down 16.9%

NASDAQ:NIVF traded down $0.15 during mid-day trading on Thursday, reaching $0.73. The stock had a trading volume of 214,771 shares, compared to its average volume of 1,076,578. NewGenIvf Group has a twelve month low of $0.69 and a twelve month high of $2,164.88. The business has a 50 day simple moving average of $2.07 and a 200 day simple moving average of $14.87. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.43 and a quick ratio of 3.37.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.